DE69409734T2 - Neue Derivate des 2-(1H)-Chinolinones, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel - Google Patents
Neue Derivate des 2-(1H)-Chinolinones, Verfahren zu ihrer Herstellung und sie enthaltende ArzneimittelInfo
- Publication number
- DE69409734T2 DE69409734T2 DE69409734T DE69409734T DE69409734T2 DE 69409734 T2 DE69409734 T2 DE 69409734T2 DE 69409734 T DE69409734 T DE 69409734T DE 69409734 T DE69409734 T DE 69409734T DE 69409734 T2 DE69409734 T2 DE 69409734T2
- Authority
- DE
- Germany
- Prior art keywords
- substituted
- branched
- linear
- unsubstituted
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940126601 medicinal product Drugs 0.000 title 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- -1 aminosulphonyl group Chemical group 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9310379A FR2709489B1 (fr) | 1993-08-31 | 1993-08-31 | Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69409734D1 DE69409734D1 (de) | 1998-05-28 |
| DE69409734T2 true DE69409734T2 (de) | 1998-11-12 |
Family
ID=9450460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69409734T Expired - Fee Related DE69409734T2 (de) | 1993-08-31 | 1994-08-31 | Neue Derivate des 2-(1H)-Chinolinones, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5536709A (de) |
| EP (1) | EP0640612B1 (de) |
| JP (1) | JP2672262B2 (de) |
| AT (1) | ATE165362T1 (de) |
| AU (1) | AU676348B2 (de) |
| CA (1) | CA2117600A1 (de) |
| DE (1) | DE69409734T2 (de) |
| DK (1) | DK0640612T3 (de) |
| ES (1) | ES2118343T3 (de) |
| FR (1) | FR2709489B1 (de) |
| NZ (1) | NZ264338A (de) |
| ZA (1) | ZA946659B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000309585A (ja) * | 1999-02-26 | 2000-11-07 | Kyorin Pharmaceut Co Ltd | ６−置換ヘテロキノリンカルボン酸誘導体とその付加塩及びそれらの製造方法 |
| FR2805260A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2805262A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides aryle ou heteroaryle quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2805261A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
| CL2008003065A1 (es) * | 2007-10-16 | 2009-07-17 | Janssen Pharmaceutica Nv | Proceso para preparar un compuesto derivado de acido carbamoil-fosfonico o del acido carbamoil-fosfinico. |
| WO2012164085A1 (en) | 2011-06-03 | 2012-12-06 | Merz Pharma Gmbh & Co. Kgaa | Glycine b antagonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4124588A (en) * | 1976-03-01 | 1978-11-07 | Sandoz, Inc. | 4-Hydroxy-quinolin-2-one-3-phosphonic acid esters |
| US4093637A (en) * | 1977-01-31 | 1978-06-06 | The United States Of America As Represented By The Secretary Of Agriculture | Alkyl 9,9(10,10)-bis(acyloxymethyl)octadecanoates as primary plasticizers for polyvinylchloride |
| US4906621A (en) * | 1985-05-24 | 1990-03-06 | Ciba-Geigy Corporation | Certain 2-carboxypiperidyl-alkylene phosphonic acids and esters thereof useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade |
| FR2683818B1 (fr) * | 1991-11-14 | 1993-12-31 | Adir Cie | Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| IS4233A (is) * | 1993-12-22 | 1995-06-23 | Astra Aktiebolag | Misleit hringtengd efnasambönd |
-
1993
- 1993-08-31 FR FR9310379A patent/FR2709489B1/fr not_active Expired - Fee Related
-
1994
- 1994-08-29 AU AU71520/94A patent/AU676348B2/en not_active Ceased
- 1994-08-29 CA CA002117600A patent/CA2117600A1/fr not_active Abandoned
- 1994-08-30 US US08/297,793 patent/US5536709A/en not_active Expired - Fee Related
- 1994-08-30 NZ NZ264338A patent/NZ264338A/en unknown
- 1994-08-30 JP JP6205464A patent/JP2672262B2/ja not_active Expired - Fee Related
- 1994-08-31 EP EP94401926A patent/EP0640612B1/de not_active Expired - Lifetime
- 1994-08-31 DE DE69409734T patent/DE69409734T2/de not_active Expired - Fee Related
- 1994-08-31 ES ES94401926T patent/ES2118343T3/es not_active Expired - Lifetime
- 1994-08-31 ZA ZA946659A patent/ZA946659B/xx unknown
- 1994-08-31 AT AT94401926T patent/ATE165362T1/de not_active IP Right Cessation
- 1994-08-31 DK DK94401926T patent/DK0640612T3/da active
-
1995
- 1995-07-10 US US08/499,946 patent/US5646132A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2709489A1 (fr) | 1995-03-10 |
| AU676348B2 (en) | 1997-03-06 |
| AU7152094A (en) | 1995-03-16 |
| DE69409734D1 (de) | 1998-05-28 |
| ZA946659B (en) | 1995-04-20 |
| US5646132A (en) | 1997-07-08 |
| JP2672262B2 (ja) | 1997-11-05 |
| ES2118343T3 (es) | 1998-09-16 |
| EP0640612B1 (de) | 1998-04-22 |
| NZ264338A (en) | 1995-10-26 |
| ATE165362T1 (de) | 1998-05-15 |
| JPH07149778A (ja) | 1995-06-13 |
| DK0640612T3 (da) | 1999-02-15 |
| FR2709489B1 (fr) | 1995-10-20 |
| EP0640612A1 (de) | 1995-03-01 |
| US5536709A (en) | 1996-07-16 |
| CA2117600A1 (fr) | 1995-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69100079T2 (de) | Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
| ATE79376T1 (de) | Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| PH23607A (en) | Amide derivatives and pharmaceutical composition containing said compounds | |
| ATE22292T1 (de) | Pyrimidoquinoxaline, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| DE69101141D1 (de) | Neue Guanidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
| AU2835192A (en) | New 3-sulfonylamino-2(1h)-quinolone compounds, process for preparing them and pharmaceutical compositions containing them | |
| DE69409734T2 (de) | Neue Derivate des 2-(1H)-Chinolinones, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| ATE3294T1 (de) | 6-aminosubstituierte n-pyrrolyl-3-pyridazinamine, deren herstellung und sie enthaltende pharmazeutische antihypertensive zusammensetzungen. | |
| DE69410359T2 (de) | Benzospiroalken-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| ATE2219T1 (de) | Phenyl-piperazin-derivate, ihre herstellung und sie enthaltende anti-agressive heilmittel. | |
| DE69217613D1 (de) | Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| DE3870167D1 (de) | N-(vinblastinoyl-23)-derivate von 1-aminomethylposphonsaeure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. | |
| ATE123487T1 (de) | Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE42098T1 (de) | 1,2,4-thiadiazine und ihre salze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und sie enthaltende arzneimittel. | |
| IL106564A (en) | Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them | |
| ATE25976T1 (de) | Substituierte 1-((3-(amino)-propoxy)-phenyl)-1(phenyl)-propan-1-ole, ihre saeureadditionssalze und quaternaeren salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| DE69419083T2 (de) | Salmycine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| SE8005779L (sv) | Nya 5-fenyl-1,3,4,5-tetrahydro-2h-1,4-benso-diazepin-2-on-derivat, sett for deras framstellning och farmaceutiska beredningar innehallande dem | |
| HUT69166A (en) | Process to preparare pharmaceutical compns. to prevent and to cure ulcus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR |
|
| 8339 | Ceased/non-payment of the annual fee |